Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis

Authors: Scott A McDonald, Rosmawati Mohamed, Maznah Dahlui, Herlianna Naning, Adeeba Kamarulzaman

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Collecting adequate information on key epidemiological indicators is a prerequisite to informing a public health response to reduce the impact of hepatitis C virus (HCV) infection in Malaysia. Our goal was to overcome the acute data shortage typical of low/middle income countries using statistical modelling to estimate the national HCV prevalence and the distribution over transmission pathways as of the end of 2009.

Methods

Multi-parameter evidence synthesis methods were applied to combine all available relevant data sources - both direct and indirect - that inform the epidemiological parameters of interest.

Results

An estimated 454,000 (95% credible interval [CrI]: 392,000 to 535,000) HCV antibody-positive individuals were living in Malaysia in 2009; this represents 2.5% (95% CrI: 2.2-3.0%) of the population aged 15-64 years. Among males of Malay ethnicity, for 77% (95% CrI: 69-85%) the route of probable transmission was active or a previous history of injecting drugs. The corresponding proportions were smaller for male Chinese and Indian/other ethnic groups (40% and 71%, respectively). The estimated prevalence in females of all ethnicities was 1% (95% CrI: 0.6 to 1.4%); 92% (95% CrI: 88 to 95%) of infections were attributable to non-drug injecting routes of transmission.

Conclusions

The prevalent number of persons living with HCV infection in Malaysia is estimated to be very high. Low/middle income countries often lack a comprehensive evidence base; however, evidence synthesis methods can assist in filling the data gaps required for the development of effective policy to address the future public health and economic burden due to HCV.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chawarski MC, Mazlan M, Schottenfeld RS: Heroin dependence and HIV infection in Malaysia. Drug Alcohol Depend. 2006, 82 (Suppl 1): S39-S42. 10.1016/S0376-8716(06)80007-4.CrossRefPubMed Chawarski MC, Mazlan M, Schottenfeld RS: Heroin dependence and HIV infection in Malaysia. Drug Alcohol Depend. 2006, 82 (Suppl 1): S39-S42. 10.1016/S0376-8716(06)80007-4.CrossRefPubMed
2.
go back to reference Vicknasingam B, Narayanan S, Navaratnam V: Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia. Drug Alcohol Rev. 2009, 28: 447-454. 10.1111/j.1465-3362.2009.00087.x.CrossRefPubMed Vicknasingam B, Narayanan S, Navaratnam V: Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia. Drug Alcohol Rev. 2009, 28: 447-454. 10.1111/j.1465-3362.2009.00087.x.CrossRefPubMed
3.
go back to reference Mohamed N, Rashid Z, Wong K, Abdullah S, Rahman M: Hepatitis C genotype & associated risks factors of patients at University Kebangsaan Malaysia Medical Centre. Pak J Med Sci. 2013, 29: 1142-1146. 10.12669/pjms.295.3610.CrossRefPubMedPubMedCentral Mohamed N, Rashid Z, Wong K, Abdullah S, Rahman M: Hepatitis C genotype & associated risks factors of patients at University Kebangsaan Malaysia Medical Centre. Pak J Med Sci. 2013, 29: 1142-1146. 10.12669/pjms.295.3610.CrossRefPubMedPubMedCentral
4.
go back to reference Suresh RL, Kananathan R, Merican I: Chronic hepatitis C-a study of 105 cases between 1990-2000. Med J Malaysia. 2001, 56: 243-247.PubMed Suresh RL, Kananathan R, Merican I: Chronic hepatitis C-a study of 105 cases between 1990-2000. Med J Malaysia. 2001, 56: 243-247.PubMed
5.
go back to reference Tan S, Menon J, Radzi M, Thein S, Mohamed R, Annuar S: The demography and risk profiles for chronic hepatitis B and C from the Malaysian Liver Registry. Med J Malaysia. 2011, 66 (Suppl. A): 31- Tan S, Menon J, Radzi M, Thein S, Mohamed R, Annuar S: The demography and risk profiles for chronic hepatitis B and C from the Malaysian Liver Registry. Med J Malaysia. 2011, 66 (Suppl. A): 31-
6.
go back to reference Sinniah M, Ooi BG: Hepatitis C-the Malaysian story. Singapore Med J. 1993, 34: 132-134.PubMed Sinniah M, Ooi BG: Hepatitis C-the Malaysian story. Singapore Med J. 1993, 34: 132-134.PubMed
7.
go back to reference Malaysia 2012 Global AIDS Response Country Progress Report. Reporting Period: January 2010 - December 2011. 2012, Ministry of Health, Kuala Lumpur, Malaysia Malaysia 2012 Global AIDS Response Country Progress Report. Reporting Period: January 2010 - December 2011. 2012, Ministry of Health, Kuala Lumpur, Malaysia
8.
go back to reference National Anti-Drug Agency (NADA): Buku Maklumat Dadah 2009 [Drug Information Book 2012]. Kajang, Malaysia: 2010. National Anti-Drug Agency (NADA): Buku Maklumat Dadah 2009 [Drug Information Book 2012]. Kajang, Malaysia: 2010.
9.
go back to reference Shepard CW, Finelli L, Alter MJ: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005, 5: 558-567. 10.1016/S1473-3099(05)70216-4.CrossRefPubMed Shepard CW, Finelli L, Alter MJ: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005, 5: 558-567. 10.1016/S1473-3099(05)70216-4.CrossRefPubMed
10.
go back to reference Thomas DL: Global control of hepatitis C: where challenge meets opportunity. Nat Med. 2013, 19: 850-858. 10.1038/nm.3184.CrossRefPubMed Thomas DL: Global control of hepatitis C: where challenge meets opportunity. Nat Med. 2013, 19: 850-858. 10.1038/nm.3184.CrossRefPubMed
11.
go back to reference Prevention and control of viral hepatitis infection: Framework for global action. 2012, WHO, Geneva Prevention and control of viral hepatitis infection: Framework for global action. 2012, WHO, Geneva
12.
go back to reference Guidelines for the screening, care and treatment of persons with hepatitis C infection. 2014, WHO, Geneva Guidelines for the screening, care and treatment of persons with hepatitis C infection. 2014, WHO, Geneva
13.
go back to reference Goubar A, Ades AE, De Angelis D, McGarrigle CA, Mercer CH, Tookey PA, Gill ON: Estimates of human immunodeficiency virus prevalence and proportion diagnosed based on Bayesian multiparameter synthesis of surveillance data. J Royal Stat Soc A (Statistics in Society). 2008, 171: 541-580. 10.1111/j.1467-985X.2007.00537.x.CrossRef Goubar A, Ades AE, De Angelis D, McGarrigle CA, Mercer CH, Tookey PA, Gill ON: Estimates of human immunodeficiency virus prevalence and proportion diagnosed based on Bayesian multiparameter synthesis of surveillance data. J Royal Stat Soc A (Statistics in Society). 2008, 171: 541-580. 10.1111/j.1467-985X.2007.00537.x.CrossRef
14.
go back to reference Presanis AM, De Angelis D, Hagy A, Reed C, Riley S, Cooper BS, Finelli L, Biedrzycki P, Lipsitch M: The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med. 2009, 6: e1000207-10.1371/journal.pmed.1000207.CrossRefPubMedPubMedCentral Presanis AM, De Angelis D, Hagy A, Reed C, Riley S, Cooper BS, Finelli L, Biedrzycki P, Lipsitch M: The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med. 2009, 6: e1000207-10.1371/journal.pmed.1000207.CrossRefPubMedPubMedCentral
15.
go back to reference Harris RJ, Ramsay M, Hope VD, Brant L, Hickman M, Foster GR, De Angelis D: Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis. Eur J Public Health. 2012, 22: 187-192. 10.1093/eurpub/ckr083.CrossRefPubMed Harris RJ, Ramsay M, Hope VD, Brant L, Hickman M, Foster GR, De Angelis D: Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis. Eur J Public Health. 2012, 22: 187-192. 10.1093/eurpub/ckr083.CrossRefPubMed
16.
go back to reference De Angelis D, Sweeting M, Ades A, Hickman M, Hope V, Ramsay M: An evidence synthesis approach to estimating Hepatitis C prevalence in England and Wales. Stat Methods Med Res. 2009, 18: 361-379. 10.1177/0962280208094691.CrossRefPubMed De Angelis D, Sweeting M, Ades A, Hickman M, Hope V, Ramsay M: An evidence synthesis approach to estimating Hepatitis C prevalence in England and Wales. Stat Methods Med Res. 2009, 18: 361-379. 10.1177/0962280208094691.CrossRefPubMed
17.
go back to reference Kavanagh K, Wallace LA, Robertson C, Wilson P, Scoular A: Estimation of the risk of tubal factor infertility associated with genital chlamydial infection in women: a statistical modelling study. Int J Epidemiol. 2013, 42: 493-503. 10.1093/ije/dyt011.CrossRefPubMed Kavanagh K, Wallace LA, Robertson C, Wilson P, Scoular A: Estimation of the risk of tubal factor infertility associated with genital chlamydial infection in women: a statistical modelling study. Int J Epidemiol. 2013, 42: 493-503. 10.1093/ije/dyt011.CrossRefPubMed
18.
go back to reference Winslow M, Subramaniam M, Ng WL, Lee A, Song G, Chan YH: Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore. Singapore Med J. 2007, 48: 504-508.PubMed Winslow M, Subramaniam M, Ng WL, Lee A, Song G, Chan YH: Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore. Singapore Med J. 2007, 48: 504-508.PubMed
19.
go back to reference Duraisamy G, Zuridah H, Ariffin MY: Prevalence of hepatitis C virus antibodies in blood donors in Malaysia. Med J Malaysia. 1993, 48: 313-316.PubMed Duraisamy G, Zuridah H, Ariffin MY: Prevalence of hepatitis C virus antibodies in blood donors in Malaysia. Med J Malaysia. 1993, 48: 313-316.PubMed
20.
go back to reference Haslina MN, Khairiah Y, Zainy DZ, Shafini MY, Rosnah B, Marini R: Seroprevalence of hepatitis C virus infection among blood donors in a teaching hospital in northeastern Malaysia. Southeast Asian J Trop Med Public Health. 2012, 43 (3): 668-673.PubMed Haslina MN, Khairiah Y, Zainy DZ, Shafini MY, Rosnah B, Marini R: Seroprevalence of hepatitis C virus infection among blood donors in a teaching hospital in northeastern Malaysia. Southeast Asian J Trop Med Public Health. 2012, 43 (3): 668-673.PubMed
21.
go back to reference Vrielink H, Reesink HW, van den Burg PJ, Zaaijer HL, Cuypers HT, Lelie PN, van der Poel CL: Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients. Transfusion. 1997, 37: 845-849. 10.1046/j.1537-2995.1997.37897424409.x.CrossRefPubMed Vrielink H, Reesink HW, van den Burg PJ, Zaaijer HL, Cuypers HT, Lelie PN, van der Poel CL: Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients. Transfusion. 1997, 37: 845-849. 10.1046/j.1537-2995.1997.37897424409.x.CrossRefPubMed
22.
go back to reference Wang JE: A study on the epidemiology of hepatitis C infection among blood donors in Singapore. J Public Health Med. 1995, 17: 387-391.PubMed Wang JE: A study on the epidemiology of hepatitis C infection among blood donors in Singapore. J Public Health Med. 1995, 17: 387-391.PubMed
23.
go back to reference Luksamijarulkul P, Thammata N, Sujirarat D, Tiloklurs M: Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form. Southeast Asian J Trop Med Public Health. 2004, 35: 147-154.PubMed Luksamijarulkul P, Thammata N, Sujirarat D, Tiloklurs M: Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form. Southeast Asian J Trop Med Public Health. 2004, 35: 147-154.PubMed
24.
go back to reference Vicknasingam B, Narayanan S, Navaratnam V: The relative risk of HIV among IDUs not in treatment in Malaysia. AIDS Care. 2009, 21: 984-991. 10.1080/09540120802657530.CrossRefPubMed Vicknasingam B, Narayanan S, Navaratnam V: The relative risk of HIV among IDUs not in treatment in Malaysia. AIDS Care. 2009, 21: 984-991. 10.1080/09540120802657530.CrossRefPubMed
25.
go back to reference Ministry of Health Malaysia and WHO: Estimation and projection of the HIV epidemic Malaysia 2009. National Consensus Workshop; 2009. Ministry of Health Malaysia and WHO: Estimation and projection of the HIV epidemic Malaysia 2009. National Consensus Workshop; 2009.
26.
go back to reference Bakar Bin HJ, Zin A: Assessment of compulsory treatment of people who use drugs in Cambodia, China, Malaysia and Viet Nam: An application of selected human rights principles. 2009, Official communication to the Office of the WHO Representative for Brunei Darussalam, Malaysia, and Singapore, Kuala Lumpur, Malaysia Bakar Bin HJ, Zin A: Assessment of compulsory treatment of people who use drugs in Cambodia, China, Malaysia and Viet Nam: An application of selected human rights principles. 2009, Official communication to the Office of the WHO Representative for Brunei Darussalam, Malaysia, and Singapore, Kuala Lumpur, Malaysia
27.
go back to reference Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, Koziel MJ: Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001, 33: 562-569. 10.1086/321909.CrossRefPubMed Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, Koziel MJ: Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001, 33: 562-569. 10.1086/321909.CrossRefPubMed
28.
go back to reference Choo MKK, El-Bassel N, Adam PCG, Gilbert L, Wu E, West BS, Bazazi AR, De Wit JBF, Ismail R, Kamarulzaman A: Prevalence and correlates of injection drug use and infections of HIV and hepatitis C virus among Malaysian fishermen. Submitted for publication. Choo MKK, El-Bassel N, Adam PCG, Gilbert L, Wu E, West BS, Bazazi AR, De Wit JBF, Ismail R, Kamarulzaman A: Prevalence and correlates of injection drug use and infections of HIV and hepatitis C virus among Malaysian fishermen. Submitted for publication.
29.
go back to reference Micallef JM, Kaldor JM, Dore GJ: Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat. 2006, 13: 34-41. 10.1111/j.1365-2893.2005.00651.x.CrossRefPubMed Micallef JM, Kaldor JM, Dore GJ: Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat. 2006, 13: 34-41. 10.1111/j.1365-2893.2005.00651.x.CrossRefPubMed
30.
go back to reference Thomas A, O’Hara B, Ligges U, Sturtz S: Making BUGS Open. R News. 2006, 6: 12-17. Thomas A, O’Hara B, Ligges U, Sturtz S: Making BUGS Open. R News. 2006, 6: 12-17.
31.
go back to reference Lunn D, Spiegelhalter D, Thomas A, Best N: The BUGS project: Evolution, critique and future directions. Stat Med. 2009, 28: 3049-3067. 10.1002/sim.3680.CrossRefPubMed Lunn D, Spiegelhalter D, Thomas A, Best N: The BUGS project: Evolution, critique and future directions. Stat Med. 2009, 28: 3049-3067. 10.1002/sim.3680.CrossRefPubMed
32.
go back to reference R: A language and environment for statistical computing. 2014, R Foundation for Statistical Computing, Vienna, Austria R: A language and environment for statistical computing. 2014, R Foundation for Statistical Computing, Vienna, Austria
33.
go back to reference Yearbook of Statistics Malaysia. 2009, Department of Statistics, Kuala Lumpur Yearbook of Statistics Malaysia. 2009, Department of Statistics, Kuala Lumpur
34.
go back to reference Dore GJ, MacDonald M, Law MG, Kaldor JM: Epidemiology of hepatitis C virus infection in Australia. Aust Fam Physician. 2003, 32: 796-798.PubMed Dore GJ, MacDonald M, Law MG, Kaldor JM: Epidemiology of hepatitis C virus infection in Australia. Aust Fam Physician. 2003, 32: 796-798.PubMed
35.
go back to reference McDonald SA, Hutchinson SJ, Schnier C, McLeod A, Goldberg DJ: Estimating the number of injecting drug users in Scotland's HCV-diagnosed population using capture-recapture methods. Epidemiol Infect. 2014, 142: 200-207.PubMed McDonald SA, Hutchinson SJ, Schnier C, McLeod A, Goldberg DJ: Estimating the number of injecting drug users in Scotland's HCV-diagnosed population using capture-recapture methods. Epidemiol Infect. 2014, 142: 200-207.PubMed
36.
go back to reference Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST: Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013, 57: 1333-1342. 10.1002/hep.26141.CrossRefPubMed Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST: Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013, 57: 1333-1342. 10.1002/hep.26141.CrossRefPubMed
37.
go back to reference Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, Amarapurkar D, Chen CH, Dou X, El Khayat H, Elshazly M, Esmat G, Guan R, Han KH, Koike K, Largen A, McCaughan G, Mogawer S, Monis A, Nawaz A, Piratvisuth T, Sanai FM, Sharara AI, Sibbel S, Sood A, Suh DJ, Wallace C, Young K, Negro F: A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 2011, 31 (Suppl 2): 61-80. 10.1111/j.1478-3231.2011.02540.x.CrossRefPubMed Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, Amarapurkar D, Chen CH, Dou X, El Khayat H, Elshazly M, Esmat G, Guan R, Han KH, Koike K, Largen A, McCaughan G, Mogawer S, Monis A, Nawaz A, Piratvisuth T, Sanai FM, Sharara AI, Sibbel S, Sood A, Suh DJ, Wallace C, Young K, Negro F: A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 2011, 31 (Suppl 2): 61-80. 10.1111/j.1478-3231.2011.02540.x.CrossRefPubMed
38.
go back to reference Sweeting M, De Angelis D, Ades A, Hickman M: Estimating the prevalence of ex-injecting drug use in the population. Stat Methods Med Res. 2009, 18 (4): 381-395. 10.1177/0962280208094704.CrossRefPubMed Sweeting M, De Angelis D, Ades A, Hickman M: Estimating the prevalence of ex-injecting drug use in the population. Stat Methods Med Res. 2009, 18 (4): 381-395. 10.1177/0962280208094704.CrossRefPubMed
Metadata
Title
Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis
Authors
Scott A McDonald
Rosmawati Mohamed
Maznah Dahlui
Herlianna Naning
Adeeba Kamarulzaman
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-014-0564-6

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.